Literature DB >> 14464244

Age and susceptibility of mice to Coxsackie A viruses.

A M LERNER, H S LEVIN, M FINLAND.   

Abstract

Mice varying in age from 1 day to 8 months were inoculated intraperitoneally with Coxsackie A virus, type 9 and studies were made of the quantity of virus in striated muscle and myocardium, the presence of neutralizing antibody in the serum, and the pathological changes in the tissues. The hind limbs of young (1- to 20-day-old) mice yielded high titers of virus and showed diffuse myositis, whereas only low yields of virus and focal myositis were obtained in older mice. In the 20-day-old mice the skeletal lesions were not accompanied by manifest symptoms and histologically showed evidence of regeneration progressing from the 3rd to the 11th day after inoculation. Older mice showed no symptoms and only focal myositis and low yields of virus were found in their hind limbs. Coxsackie A9 virus replicated to relatively low titers in the hearts of young (1- to 40-day-old) mice without producing any demonstrable lesions whereas frank myocarditis with high yields of virus were demonstrated in mice infected at 8 months of age. The data suggest that at least for the 2 strains used, the adult mouse should be considered susceptible to subclinical infection with Coxsackie A9 virus. Neither subclinical infection, nor antibody formation was demonstrable in young adult mice inoculated with a strain of Coxsackie A4 virus.

Entities:  

Keywords:  AGING; COXSACKIE VIRUSES

Mesh:

Year:  1962        PMID: 14464244      PMCID: PMC2137516          DOI: 10.1084/jem.115.4.745

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  [Study of the Coxsackie virus: development of lesions in the suckling mouse].

Authors:  R CAMAIN; P BRES
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-03

2.  Infections due to Coxsackie virus group A, type 9, in Boston, 1959, with special reference to exanthems and pneumonia.

Authors:  A M LERNER; J O KLEIN; H S LEVIN; M FINLAND
Journal:  N Engl J Med       Date:  1960-12-22       Impact factor: 91.245

3.  Adsorption, multiplication, and cytopathogenicity of enteroviruses (poliomyelitis, Coxsackie, and ECHO groups) in susceptible and resistant monkey kidney cells.

Authors:  G D HSIUNG; J L MELNICK
Journal:  J Immunol       Date:  1958-01       Impact factor: 5.422

4.  Nutrition needs of mammalian cells in tissue culture.

Authors:  H EAGLE
Journal:  Science       Date:  1955-09-16       Impact factor: 47.728

5.  Virus myocarditis; pathologic and experimental studies.

Authors:  E C H SCHMIDT
Journal:  Am J Pathol       Date:  1948-01       Impact factor: 4.307

6.  The morbid anatomy of experimental Coxsackie virus infection.

Authors:  R GIFFORD; G DALLDORF
Journal:  Am J Pathol       Date:  1951 Nov-Dec       Impact factor: 4.307

7.  The mammalian cell-virus relationship. II. Adsorption, reception, and eclipse of poliovirus by HeLa cells.

Authors:  J J HOLLAND; L C McLAREN
Journal:  J Exp Med       Date:  1959-05-01       Impact factor: 14.307

8.  Neuropathogenicity of group A Coxsackie viruses.

Authors:  G DALLDORF
Journal:  J Exp Med       Date:  1957-07-01       Impact factor: 14.307

9.  Passage of Coxsackie virus (Connecticut-5 strain) in adult mice with production of pancreatic disease.

Authors:  A M PAPPENHEIMER; L J KUNZ; S RICHARDSON
Journal:  J Exp Med       Date:  1951-07-01       Impact factor: 14.307

10.  Lesions caused in suckling mice by certain viruses isolated from cases of so called non-paralytic poliomyelitis and of pleurodynia.

Authors:  A M PAPPENHEIMER; J B DANIELS; F S CHEEVER; T H WELLER
Journal:  J Exp Med       Date:  1950-08       Impact factor: 14.307

View more
  12 in total

1.  COXSACKIE VIRUS B3 MYOCARDITIS IN MICE. AN ELECTRON MICROSCOPIC, IMMUNOFLUORESCENT AND VIRUS-ASSAY STUDY.

Authors:  E R RABIN; S A HASSAN; A B JENSON; J L MELNICK
Journal:  Am J Pathol       Date:  1964-05       Impact factor: 4.307

Review 2.  CELLULAR SUSCEPTIBILITY TO ENTEROVIRUSES.

Authors:  C M KUNIN
Journal:  Bacteriol Rev       Date:  1964-12

3.  MULTIPLICATION OF BOSTON STRAINS OF COXSACKIEVIRUS A9 IN THE ADULT MOUSE HEART.

Authors:  F M WILSON; A HASHIMI; A M LERNER
Journal:  J Bacteriol       Date:  1965-08       Impact factor: 3.490

4.  Neutralizing antibody to polioviruses in normal human urine.

Authors:  A M LERNER; J S REMINGTON; M FINLAND
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

5.  Symptomless myocarditis and myalgia in viral and Mycoplasma pneumoniae infections.

Authors:  D Lewes; D J Rainford; W F Lane
Journal:  Br Heart J       Date:  1974-09

6.  Myocarditis due to coxsackie group A type 9 virus. Clinical and experimental study.

Authors:  G Christodoulopoulou; M Havredaki
Journal:  Arch Gesamte Virusforsch       Date:  1968

7.  Residual pathologic changes following murine coxsackie A and B myocarditis.

Authors:  F M Wilson; Q R Miranda; J L Chason; A M Lerner
Journal:  Am J Pathol       Date:  1969-05       Impact factor: 4.307

8.  Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise.

Authors:  B G Gatmaitan; J L Chason; A M Lerner
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

9.  [Mouse disease due to vesicular stomatitis virus. I. Spread of the virus dependent on the age of the mouse].

Authors:  D Falke; W P Rowe
Journal:  Arch Gesamte Virusforsch       Date:  1965

10.  In vitro and in vivo antipicornavirus activity of some phenoxypyridinecarbonitriles.

Authors:  M T Kenny; J K Dulworth; H L Torney
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.